Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Loibner, M; Buzina, W; Viertler, C; Groelz, D; Hausleitner, A; Siaulyte, G; Kufferath, I; Kölli, B; Zatloukal, K.
Pathogen Inactivating Properties and Increased Sensitivity in Molecular Diagnostics by PAXgene, a Novel Non-Crosslinking Tissue Fixative.
PLoS One. 2016; 11(3):e0151383-e0151383
Doi: 10.1371/journal.pone.0151383
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Loibner Martina
- Zatloukal Kurt
- Co-Autor*innen der Med Uni Graz
- Buzina Walter
- Hausleitner Anton
- Siaulyte Gintare
- Viertler Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Requirements on tissue fixatives are getting more demanding as molecular analysis becomes increasingly relevant for routine diagnostics. Buffered formaldehyde in pathology laboratories for tissue fixation is known to cause chemical modifications of biomolecules which affect molecular testing. A novel non-crosslinking tissue preservation technology, PAXgene Tissue (PAXgene), was developed to preserve the integrity of nucleic acids in a comparable way to cryopreservation and also to preserve morphological features comparable to those of formalin fixed samples. Because of the excellent preservation of biomolecules by PAXgene we investigated its pathogen inactivation ability and biosafety in comparison to formalin by in-vitro testing of bacteria, human relevant fungi and human cytomegalovirus (CMV). Guidelines for testing disinfectants served as reference for inactivation assays. Furthermore, we tested the properties of PAXgene for detection of pathogens by PCR based assays. All microorganisms tested were similarly inactivated by PAXgene and formalin except Clostridium sporogenes, which remained viable in seven out of ten assays after PAXgene treatment and in three out of ten assays after formalin fixation. The findings suggest that similar biosafety measures can be applied for PAXgene and formalin fixed samples. Detection of pathogens in PCR-based diagnostics using two CMV assays resulted in a reduction of four to ten quantification cycles of PAXgene treated samples which is a remarkable increase of sensitivity. PAXgene fixation might be superior to formalin fixation when molecular diagnostics and highly sensitive detection of pathogens is required in parallel to morphology assessment.
- Find related publications in this database (using NLM MeSH Indexing)
- Bacteria - genetics
- Cross-Linking Reagents - pharmacology
- Cytomegalovirus - drug effects
- Fixatives - pharmacology
- Formaldehyde - pharmacology
- Fungi - genetics
- Humans -
- Microbial Viability -
- Pathology, Molecular -
- Real-Time Polymerase Chain Reaction -
- Tissue Fixation - methods
- Virus Inactivation - drug effects